Recently, a dual approach was tested: CK2 and epidermal growth factor receptor (EGFR), both of which are overexpressed in glioblastoma [24], were targeted by morpholino oligomeres attached to nanobioconjugates [25], in a mouse model of intracranial human glioblastoma. This evidence concerns the gene EGFR and glioblastoma.